Salt-inducible kinase 3 is a novel mitotic regulator and a target for enhancing antimitotic therapeutic-mediated cell death
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Salt-inducible kinase 3 is a novel mitotic regulator and a target for enhancing antimitotic therapeutic-mediated cell death
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 5, Issue 4, Pages e1177-e1177
Publisher
Springer Nature
Online
2014-04-17
DOI
10.1038/cddis.2014.154
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Tumor Suppressor Kinase LKB1 Activates the Downstream Kinases SIK2 and SIK3 to Stimulate Nuclear Export of Class IIa Histone Deacetylases
- (2013) Donald R. Walkinshaw et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SIK3 is essential for chondrocyte hypertrophy during skeletal development in mice
- (2012) S. Sasagawa et al. DEVELOPMENT
- Depletion of p31cometProtein Promotes Sensitivity to Antimitotic Drugs
- (2012) Hoi Tang Ma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Salt-inducible kinases regulate growth through the Hippo signalling pathway in Drosophila
- (2012) Michael C. Wehr et al. NATURE CELL BIOLOGY
- Involvement of SIK3 in Glucose and Lipid Homeostasis in Mice
- (2012) Tatsuya Uebi et al. PLoS One
- How protein kinases co-ordinate mitosis in animal cells
- (2011) Hoi Tang Ma et al. BIOCHEMICAL JOURNAL
- A Hormone-Dependent Module Regulating Energy Balance
- (2011) Biao Wang et al. CELL
- CDK1 inhibitors antagonize the immediate apoptosis triggered by spindle disruption but promote apoptosis following the subsequent rereplication and abnormal mitosis
- (2011) Ying Wai Chan et al. CELL CYCLE
- Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays
- (2011) M. G. Manfredi et al. CLINICAL CANCER RESEARCH
- Determinants of Mitotic Catastrophe on Abrogation of the G2 DNA Damage Checkpoint by UCN-01
- (2011) K. F. On et al. MOLECULAR CANCER THERAPEUTICS
- Identification of salt-inducible kinase 3 as a novel tumor antigen associated with tumorigenesis of ovarian cancer
- (2011) S Charoenfuprasert et al. ONCOGENE
- MK-5108, a Highly Selective Aurora-A Kinase Inhibitor, Shows Antitumor Activity Alone and in Combination with Docetaxel
- (2010) T. Shimomura et al. MOLECULAR CANCER THERAPEUTICS
- Loss of Histone Deacetylase 4 Causes Segregation Defects during Mitosis of p53-Deficient Human Tumor Cells
- (2009) B. Cadot et al. CANCER RESEARCH
- Cyclin A2-Cyclin-Dependent Kinase 2 Cooperates with the PLK1-SCF -TrCP1-EMI1-Anaphase-Promoting Complex/Cyclosome Axis To Promote Genome Reduplication in the Absence of Mitosis
- (2009) H. T. Ma et al. MOLECULAR AND CELLULAR BIOLOGY
- Histone deacetylase inhibitors and genomic instability
- (2008) Grégory Eot-Houllier et al. CANCER LETTERS
- The Kinetics of p53 ActivationVersusCyclin E Accumulation Underlies the Relationship between the Spindle-assembly Checkpoint and the Postmitotic Checkpoint
- (2008) Ying Wai Chan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started